19Sep
15Sep
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology (“ACR”) 2018 Annual Meeting being held October 19-24, 2018 in Chicago, Illinois. Read more >>
14Sep
Visual ability, reading improves with eSight low vision device
Study participants who wore the head-mounted low vision device, eSight, experienced immediate improvements in visual ability, facial recognition and activities of daily living, according to researchers. Read more >>
14Sep
KnipBio completes trial on feed efficacy product
US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials. Read more >>
13Sep
KnipBio heralds astaxanthin-rich protein feed test outcome
Next stage in fish nutrition project moves to large scale field trials. Read More >>
13Sep
Wasabi Secures $68 Million Funding Round, Bypasses Traditional VC Financing
Wasabi, the hot cloud storage company, today announces the closing of a Series B financing round totaling $68 million. Wasabi refrained from conventional venture capital, preferring instead to raise money from industry veterans and family offices. The investment is a testament to Wasabi’s progress in becoming a leading vendor of cheap, fast, and secure cloud storage. In just over a year, Wasabi has acquired more than 3,000 customers across a wide range of industries. Read more >>
07Sep
Study highlights clinical effectiveness of eSight
Patients experienced ‘significant improvement’ in visual function measures when wearing the assistive technology device. Read more >>
05Sep
Pixability Announces Launch Of Video Creative Decisioning Engine
Patented AI-Driven Technology Maximizes Video Creative Effectiveness on YouTube. Read more >>
05Sep
Publication of eQUEST Study Results Demonstrate that eSight 3 is a Clinically Effective Device for the Visually Impaired
Significant results to be published in September 2018 issue of Optometry and Vision Science. Read more >>
05Sep